Modular Medical, Inc.
For the period ended Mar 12, 2026. Filed Mar 13, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Mar 12, 2026 · Filed Mar 13, 2026
Use the contents to explore the available documents and sections.
Contents
Cover page
Show cover page
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of report (Date of earliest event reported): March 12, 2026
MODULAR MEDICAL, INC.
(Exact name of registrant as specified in its charter)
| Nevada | 001-41277 | 87-0620495 |
|---|---|---|
| (State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
| 10740 Thornmint Road, San Diego, California | 92127 |
|---|---|
| (Address of principal executive offices) | (Zip Code) |
858-800-3500
(Registrant’s telephone number, including area code)
10740 Thornmint Road
San Diego, CA 92127
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered |
|---|---|---|
| Common Stock | MODD | The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 ).
Emerging growth company☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
On March 12, 2026, Modular Medical, Inc. (the “Company”) implemented an employee lay-off and eliminated certain positions (the “Reductions”) to reduce the Company’s operating expense and cash burn, as the Company prioritizes business activities and projects that it believes will have a higher return on investment. The Reductions impacted 20 positions, or approximately 29% of the Company’s workforce. The Company expects that the Reductions will reduce annual operating expenses by approximately $3.4 million.
The Company estimates that the total non-recurring charges will approximate $0.1 million to $0.2 million in connection with the Reductions, primarily consisting of severance payments. The Company expects that the majority of the charges would be incurred by the quarter ending June 30, 2026. The charges that the Company expects to incur and the estimated cost savings are subject to a number of assumptions, and actual expenses may differ materially from the estimates disclosed.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Modular Medical, Inc. | |
| Date: March 13, 2026 | /s/ James E. Besser |
|---|---|
| James Besser | |
| Chief Executive Officer |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.